IDYA
Ideaya Biosciences Inc
NASDAQ: IDYA · HEALTHCARE · BIOTECHNOLOGY
$28.05
-3.41% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$17 – $39
Volume
1.3M
Ideaya Biosciences Inc (IDYA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $17.48M | $96.54M | $113.00M | $298.27M | $381.35M | $387.97M | $649.32M | $1.12B | $1.11B |
| Cash & equivalents | $5.96M | $20.50M | $34.07M | $72.04M | $92.05M | $68.63M | $157.02M | $84.38M | $112.83M |
| Current assets | $13.58M | $90.67M | $101.65M | $288.61M | $251.00M | $370.45M | $532.63M | $689.71M | $666.73M |
| Total liabilities | $33.22M | $145.49M | $12.60M | $100.00M | $79.83M | $38.51M | $28.23M | $64.94M | $86.39M |
| Current liabilities | $2.43M | $5.41M | $6.94M | $38.64M | $45.16M | $31.72M | $27.10M | $46.07M | $58.81M |
| Long-term debt | $3.21M | $0.00 | — | — | — | — | — | — | — |
| Shareholder equity | $-15.74M | $-48.95M | $100.40M | $198.27M | $301.51M | $349.45M | $621.09M | $1.06B | $1.02B |
| Retained earnings | $-16.17M | $-50.52M | $-92.49M | $-126.99M | $-176.75M | $-235.40M | $-348.36M | $-622.84M | $-736.54M |
| Accounts receivable | — | — | — | $1.88M | $1.10M | $211000.00 | $18000.00 | $3000.00 | — |
| Inventory | $0.00 | $0.00 | — | — | $-121.29M | $-8.32M | $532.61M | — | — |
| Goodwill | $0.00 | $0.00 | — | — | — | — | — | — | — |